ABOLANLE AHMED-OREPITAN: Open Payments
NPI 1295397305 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $126 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Alcresta Therapeutics, Inc. | 1 | $134 |
| Hologic Sales and Service, LLC | 1 | $115 |
| Amgen Inc. | 1 | $95 |
Products named: RELIZORB, APTIMA, EVENITY.
Industry payments across DC — which companies pay providers there.
